samedi 27 septembre 2014

Strategy to reduce side effects in modern cancer therapy

A new strategy for reducing the often serious side effects of an important class of modern anticancer drugs -- tyrosine kinase inhibitors has been developed by an international team of researchers. The novel drug is supposed to restrict its activity with high selectivity to the malignant tumor.

Strategy to reduce side effects in modern cancer therapy

Aucun commentaire:

Enregistrer un commentaire